Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value:
$153.17M
Total Bought:
$0
Total Sold:
$9.94M
Net Transaction:
-$9.94M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Innoviva, Inc.(INVA)1,890,6041,890,6040$42.94M$40.10M26.18%-$2.84M
Ironwood Pharmaceuticals IncCL A9,188,6359,188,6350$38.68M$36.48M23.82%-$2.21M
Amarin Corp PlcADR1,673,3951,287,090-386,305$26.67M$16.73M10.92%-$9.94M
Lantheus Holdings, Inc.(LNTH)166,919166,9190$18.52M$16.61M10.85%-$1.90M
Neurocrine Biosciences, Inc.(NBIX)116,533116,5330$19.64M$16.53M10.79%-$3.11M
Cytokinetics, Incorporated(CYTK)228,623228,6230$19.48M$15.07M9.84%-$4.41M
Biohaven Ltd.(BHVN)582,312582,3120$8.66M$7.77M5.08%-$890.9K
Regeneron Pharmaceuticals, Inc.(REGN)4,1904,1900$2.61M$3.18M2.07%+$564.5K
Vor Biopharma Inc.(VOR)25,39925,3990$467.6K$484.6K0.32%+$17.0K
Biogen Inc.(BIIB)9509500$205.3K$214.6K0.14%+$9.3K
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q3 2026 | TickerTrail